Treatment with Upadacitinib in Active Psoriatic Arthritis: Efficacy and Safety Data of the First 192 Patients from the UPJOINT Study, a Multicentre, Observational Study in Clinical Practice

Abstract Introduction Our aim was to investigate the efficacy and safety of upadacitinib (UPA) in patients with either oligo- or polyarticular active psoriatic arthritis (PsA) using routine clinical practice data from an observational, prospective, multicentre study. Methods This interim analysis co...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Rheumatology and Therapy
المؤلفون الرئيسيون: Stephanie G. Werner, Xenofon Baraliakos, Sabine Reckert, Martin Bohl-Bühler, Marie-Claude Laliberté, Tanya Girard, Katharina Jeromin, Nikola Baschuk, Björn Fritz, Louis Bessette, Axel J. Hueber
التنسيق: مقال
اللغة:الإنجليزية
منشور في: Adis, Springer Healthcare 2023-09-01
الموضوعات:
Upadacitinib
Psoriatic arthritis
Efficacy
Safety
Minimal disease activity
Very low disease activity
الوصول للمادة أونلاين:https://doi.org/10.1007/s40744-023-00589-3

الانترنت

https://doi.org/10.1007/s40744-023-00589-3

مواد مشابهة